A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study

We herein present a prospective multicentre experience of long-acting injectable (LAI) cabotegravir/rilpivirine from 11 different HIV clinics in northern Italy, focusing on the regimen's effectiveness, durability and safety in a real-life setting. We included all people who received at least on...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of antimicrobial chemotherapy Vol. 80; no. 10; p. 2732
Main Authors:	Mazzitelli, Maria, Cozzolino, Claudia, Yaacoub, Dina, Pieri, Angela, Erne, Elke, Puzzolante, Cinzia, Fontana, Beatrice, Giglia, Maddalena, Rigamonti, Claudio, Cordioli, Maddalena, Zanchi, Chiara, Fasani, Giada, Lattuada, Emanuela, Battagin, Giuliana, Nicolè, Stefano, Malena, Marina, Rossi, Maria Cristina, Piacentini, Daniela, Raumer, Francesca, Scaglione, Vincenzo, Lanzafame, Massimiliano, Calza, Leonardo, Mussini, Cristina, Cattelan, Annamaria
Format:	Journal Article
Language:	English
Published:	England 03.10.2025
Subjects:	Adult Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Diketopiperazines Female HIV Infections - drug therapy HIV Infections - virology HIV-1 - drug effects Humans Italy Male Middle Aged Prospective Studies Pyridones - administration & dosage Pyridones - adverse effects Pyridones - therapeutic use Rilpivirine - administration & dosage Rilpivirine - adverse effects Rilpivirine - therapeutic use Treatment Outcome Viral Load Italy
ISSN:	1460-2091, 1460-2091
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!